ESR1 and breast carcinoma: In xenograft mice implanted with MCF-7 cells, an ER-positive and PR-positive breast cancer cell line, treatment using AZD2014 or the selective estrogen receptor degrader fulvestrant and the combination of the two drugs were assessed.